Wells Fargo & Company Mirum Pharmaceuticals, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 38,114 shares of MIRM stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,114
Previous 7,875
383.99%
Holding current value
$1.5 Million
Previous $197,000
561.42%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MIRM
# of Institutions
173Shares Held
54.2MCall Options Held
96.1KPut Options Held
54.8K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$255 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.99MShares$196 Million0.09% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$172 Million4.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.61MShares$142 Million2.18% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$127 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.44B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...